Reaction Details Report a problem with these data
Target
B-cell lymphoma 6 protein [5-129]
Ligand
BDBM522252
Substrate
n/a
Meas. Tech.
HTRF Assay
IC50
12.3±n/a nM
Citation
 Bellenie, BR; Cheung, KM; Davis, OA; Hoelder, S; Huckvale, R; Lloyd, MG 2-quinolone derived inhibitors of BCL6 US Patent  US11161839 Publication Date 11/2/2021 
Target
Name:
B-cell lymphoma 6 protein [5-129]
Synonyms:
BCL5 | BCL6 | BCL6_HUMAN | BTB domain-containing protein 27 (BCL-6)(5-129) | LAZ3 | ZBTB27 | ZNF51
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14310.07
Organism:
Homo sapiens (Human)
Description:
aa 5-129
Residue:
125
Sequence:
ADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE
  
Inhibitor
Name:
BDBM522252
Synonyms:
US11161839, Example 7a
Type:
Small organic molecule
Emp. Form.:
C29H31ClN8O2
Mol. Mass.:
559.062
SMILES:
C[C@H]1CN(C[C@@H](C)O1)c1cnc(nc1)C(C)(C)Nc1cc(=O)n(C)c2ccc(Nc3ccnc(Cl)c3C#N)cc12 |r|
Structure:
Search PDB for entries with ligand similarity: